BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. REGN
2. CRWD
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results

BioMarin Pharma (BMRN) Tops Q4 EPS by 17c, Offers FY Guidance

February 26, 2020 4:08 PM EST

BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of $0.08, $0.17 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $454.4 million versus the consensus estimate of $459.33 million.

GUIDANCE:

BioMarin Pharma sees FY2020 revenue of $1.95-2.05 billion, versus the consensus of $1.95... More